Legal & Regulatory Issues

A transmittal from the Centers for Medicare & Medicaid Services has listed four new Category III codes for the Hospital Outpatient Prospective Payment System set to take effect on July 1.

The U.S. Supreme Court has agreed to hear a case filed by the Mayo Clinic and the University of Minnesota contesting a decision by the Treasury Department to levy Social Security taxes on medical residents, according to a report by…

Massachusetts Attorney General Martha Coakley will hold hearings from June 8 to July 1 on the $830 million sale of Caritas Christi Health Care to the private equity firm Cerberus Capital Management, according to a report by the Boston Herald.

North Carolina-based Novant Health has sued Aetna over data used by the insurer in contract negotiations, according to the Charlotte Business Journal.

Hospira is voluntarily expanding its recall of its Propofol Injectable Emulsion 1% and Liposyn products, including Liposyn II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20% and Liposyn III 30%, due to particulate matter found in some of…

Medtronic has eliminated two executive posts, one in cardiovascular business and one in spinal and biologics, as part of changes stemming from the company's decision to consolidate its business structure, according to a report in the Wall Street Journal.

Federal investigators are looking into billing practices at Dallas' University of Texas Southwestern Medical Center and Parkland Memorial Hospital, after previous investigations discovered the hospitals had billed the government for services provided by faculty physicians when they were performed by…

The Colorado Hospital Association filed a lawsuit against new state regulations on off-campus sites and hospital expansions, according to a report by the Denver Business Journal.

Nikkie LaFleur of Lake Charles, La., was sentenced to 37 months' imprisonment after pleading guilty to three counts of healthcare fraud in March, according to an Associated Press report on KLFY News.

Teva Pharmaceutical Industries told the U.S. Food and Drug Administration it will stop manufacturing propofol, which could further exacerbate a months-long shortage of the anesthetic, according to a report in the Wall Street Journal.